S286: LONG-TERM EFFICACY AND SAFETY RESULTS FROM AN ONGOING OPEN-LABEL PHASE 2 STUDY OF PARSACLISIB FOR THE TREATMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

oleh: W. Barcellini, I. Murakhovskaya, L. Terriou, F. Pane, A. Patriarca, K. Butler, S. Moran, S. Wei, U. Jäger

Format: Article
Diterbitkan: Wiley 2022-06-01

Deskripsi

No description available for this item.